滄州明珠(002108.SZ):截至目前公司蕪湖隔膜產品已小批量供貨
格隆匯12月27日丨滄州明珠(002108.SZ)在投資者互動平台表示,公司一直關注股價情況,良好的市值是公司和全體股東共同的願望,也是公司努力的方向。2023年度公司實施了股份回購,回購後用於股權激勵,有利於進一步完善公司長效激勵機制,以此構建創新的管理團隊持股的長期激勵與約束機制,激勵核心員工創造更大價值,確保公司長期經營目標的實現,推動全體股東的利益一致與收益共享,提升公司整體價值;截至目前公司蕪湖隔膜產品已小批量供貨;據瞭解,大股東股票質押是基於其自身的資金需求而做出的,截至目前無平倉風險;後續隨着隔膜產能的逐漸釋放,公司也會積極開拓市場;截至目前公司沒有與您所述公司合作的相關信息。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.